Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

(2013) Marcos Hortes N Chagas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

(2013) C.H. Schenck et al.   SLEEP MEDICINE

Treatment outcomes in REM sleep behavior disorder

(2013) Stuart J. McCarter et al.   SLEEP MEDICINE

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

(2010) D. O. Claassen et al.   NEUROLOGY

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

(2009) David A. Price et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.

(2008) Eric Murillo-Rodríguez et al.   BEHAVIORAL NEUROSCIENCE

Cannabidiol for the treatment of psychosis in Parkinson’s disease

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA